Related Experiment Video

Updated: May 10, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
09:25

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

Serious group a streptococcal infections

Christopher J Wong1, Dennis L Stevens

  • 1Division of General Internal Medicine, Department of Medicine, University of Washington, 4245 Roosevelt Way Northeast, Box 354760, Seattle, WA 98105, USA. cjwong@uw.edu

The Medical Clinics of North America
|July 2, 2013
PubMed

Insights

Group A Streptococcus (GAS) causes severe infections globally. Early diagnosis and treatment with penicillin, sometimes combined with clindamycin, are crucial for managing invasive GAS disease.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Group A Streptococcus (GAS) causes a range of illnesses, from noninvasive to severe invasive infections.
  • Since the late 1980s, there has been an observed increase in the virulence of GAS infections, leading to significant morbidity and mortality worldwide.
  • Invasive GAS infections pose a substantial public health challenge, particularly in North America.

Purpose of the Study:

  • To review the pathophysiology of invasive group A Streptococcus infections.
  • To outline the clinical manifestations of invasive GAS disease.
  • To discuss current treatment strategies for invasive group A Streptococcus infections.

Main Methods:

  • This review synthesizes existing literature on invasive group A Streptococcus infections.
  • Information was gathered on the epidemiology, pathogenesis, clinical presentation, and therapeutic approaches.
  • The review focuses on understanding the increasing virulence and management of GAS.

Main Results:

  • Invasive GAS infections are associated with high rates of morbidity and mortality.
  • Penicillin is the primary treatment of choice for GAS infections.
  • Clindamycin is recommended as an adjunct therapy for high-risk invasive GAS cases.

Conclusions:

  • Early and accurate diagnosis of invasive GAS infections is critical for effective patient outcomes.
  • Timely administration of appropriate antibiotic therapy, guided by clinical recognition, is essential.
  • Understanding the evolving nature of GAS virulence is key to combating these serious infections.

More Related Videos

A Murine Model of Group B Streptococcus Vaginal Colonization10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased by a...